Ganetespib: research and clinical development

Autor Jhaveri, Komal, Modi, Shanu
Vydáno v Onco Targets Ther (2015)

HER2 breast cancer therapies: a review

Autor Murphy, Conleth G, Modi, Shanu
Vydáno 2009

Targeting the cyclin D–cyclin-dependent kinase (CDK)4/6–retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current stat...

Autor Spring, Laura, Bardia, Aditya, Modi, Shanu
Vydáno v Discov Med (2016)

Unlocking the potential of antibody–drug conjugates for cancer therapy

Autor Drago, Joshua Z., Modi, Shanu, Chandarlapaty, Sarat
Vydáno v Nat Rev Clin Oncol (2021)

Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers

Autor Jhaveri, Komal, Taldone, Tony, Modi, Shanu, Chiosis, Gabriela
Vydáno 2011

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

Autor Patel, Hardik J, Modi, Shanu, Chiosis, Gabriela, Taldone, Tony
Vydáno 2011

Chaperome heterogeneity and its implications for cancer study and treatment

Autor Wang, Tai, Rodina, Anna, Dunphy, Mark P., Corben, Adriana, Modi, Shanu, Guzman, Monica L., Gewirth, Daniel T., Chiosis, Gabriela
Vydáno v J Biol Chem (2019)

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Autor Corben, Adriana D., Uddin, Mohammad M., Crawford, Brooke, Farooq, Mohammad, Modi, Shanu, Gerecitano, John, Chiosis, Gabriela, Alpaugh, Mary L.
Vydáno v J Vis Exp (2014)

Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer

Autor Freites-Martinez, Azael, Shapiro, Jerry, Chan, Donald, Fornier, Monica, Modi, Shanu, Gajria, Devika, Dusza, Stephen, Goldfarb, Shari, Lacouture, Mario E.
Vydáno v JAMA Dermatol (2018)

Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer

Autor Krop, Ian E., Modi, Shanu, LoRusso, Patricia M., Pegram, Mark, Guardino, Ellie, Althaus, Betsy, Lu, Dan, Strasak, Alexander, Elias, Anthony
Vydáno v Breast Cancer Res (2016)

The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation

Autor Yang, T. Jonathan, Morrow, Monica, Modi, Shanu, Zhang, Zhigang, Krause, Kate, Siu, Chun, McCormick, Beryl, Powell, Simon N., Ho, Alice Y.
Vydáno v Ann Surg Oncol (2015)

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

Autor Modi, Shanu, Saura, Cristina, Henderson, Charles, Lin, Nancy U., Mahtani, Reshma, Goddard, Jill, Rodenas, Eduardo, Hudis, Clifford, O’Shaughnessy, Joyce, Baselga, Jose
Vydáno 2013

Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5‐Year Follow‐up

Autor Wang, Rui, Smyth, Lillian M., Iyengar, Neil, Chandarlapaty, Sarat, Modi, Shanu, Jochelson, Maxine, Patil, Sujata, Norton, Larry, Hudis, Clifford A., Dang, Chau T.
Vydáno v Oncologist (2019)

Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer

Autor Chandarlapaty, Sarat, Sakr, Rita A., Giri, Dilip, Patil, Sujata, Heguy, Adriana, Morrow, Monica, Modi, Shanu, Norton, Larry, Rosen, Neal, Hudis, Clifford, King, Tari A.
Vydáno 2012

Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging and lung metastases in patients with breast cancer

Autor Morris, Patrick G., Zhou, Xi Kathy, Milne, Ginger L., Goldstein, Daniel, Hawks, Laura C., Dang, Chau T., Modi, Shanu, Fornier, Monica N., Hudis, Clifford A., Dannenberg, Andrew J.
Vydáno 2013

A Phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer

Autor Jhaveri, Komal, Drago, Joshua Z., Shah, Payal Deepak, Wang, Rui, Pareja, Fresia, Ratzon, Fanni, Iasonos, Alexia, Patil, Sujata, Rosen, Neal, Fornier, Monica N., Sklarin, Nancy T., Chandarlapaty, Sarat, Modi, Shanu
Vydáno v Clin Cancer Res (2021)

Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia

Autor Freites-Martinez, Azael, Chan, Donald, Sibaud, Vincent, Shapiro, Jerry, Fabbrocini, Gabriella, Tosti, Antonella, Cho, Juhee, Goldfarb, Shari, Modi, Shanu, Gajria, Devika, Norton, Larry, Paus, Ralf, Cigler, Tessa, Lacouture, Mario E.
Vydáno v JAMA Dermatol (2019)

Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions

Autor Jhaveri, Komal, Ochiana, Stefan O, Dunphy, Mark PS, Gerecitano, John F, Corben, Adriana D, Peter, Radu I, Janjigian, Yelena Y, Gomes-DaGama, Erica M, Koren, John, Modi, Shanu, Chiosis, Gabriela
Vydáno 2014

Biomarkers that Predict Sensitivity to Heat Shock Protein 90 Inhibitors (HSP90i)

Autor Jhaveri, Komal, Chandarlapaty, Sarat, Iyengar, Neil, Morris, Patrick G., Corben, Adriana D, Patil, Sujata, Akram, Muzaffar, Towers, Russell, Sakr, Rita A, King, Tari A, Norton, Larry, Rosen, Neal, Hudis, Clifford, Modi, Shanu
Vydáno v Clin Breast Cancer (2015)

Pilot study of (68)Ga-DOTA-F(ab′)(2)-trastuzumab in patients with breast cancer

Autor Beylergil, Volkan, Morris, Patrick G., Smith-Jones, Peter M., Modi, Shanu, Solit, David, Hudis, Clifford A., Lu, Yang, O’Donoghue, Joseph, Lyashchenko, Serge K., Carrasquillo, Jorge A., Larson, Steven M., Akhurst, Timothy J.
Vydáno 2013